OpenSourceMalaria:Compound Series: Difference between revisions
From OpenWetWare
Jump to navigationJump to search
Matthew Todd (talk | contribs) (Added new page on repurposing) |
Matthew Todd (talk | contribs) (added epigenetic regulation of lifecycle page) |
||
Line 16: | Line 16: | ||
[[OpenSourceMalaria:Other_GSK_Series_Under_Consideration |'''Other Possible GSK Series''']] | [[OpenSourceMalaria:Other_GSK_Series_Under_Consideration |'''Other Possible GSK Series''']] | ||
[[OpenSourceMalaria:Epigenetic Regulation of Life Cycle | '''Epigenetic Regulation of Lifecycle''']] |
Revision as of 16:42, 15 December 2014
A summary of progress in the OSM project may be found in the Story so Far. The pages below include the technical detail of the individual series examined and are written for scientific contributors.
Series 1: GSK Arylpyrroles (being written up)
Series 2: GSK Triazoloureas (parked)
Series 3: GSK Thienopyrimidines (final compounds being made)
Series 4: Triazolopyrazines (TPs) (currently most active)